RNA- Avidity Biosciences, Inc.

Name: Avidity Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Avidity Biosciences, Inc. (RNA) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. RNA is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Boyce Sarah	283.4K	$3.70M	-
Other	Gallagher Kathleen P.	205.0K	$2.68M	-
Other	Mosbrooker Eric	127.0K	$1.66M	-
Other	McCarthy Teresa	116.9K	$1.53M	-
Other	Flanagan W. Michael	91.6K	$1.20M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Jan 7, 2026	Boyce Sarah	President And CEO	Sell	8,576	$72.23	$619,444.48	-2.9%
Jan 7, 2026	Calderaro Charles III	Chief Technical Officer	Sell	3,727	$72.23	$269,201.21	-7.0%
Jan 7, 2026	McCarthy Teresa	Chief Human Resources Officer	Sell	1,965	$72.23	$141,931.95	-1.7%
Jan 7, 2026	Moriarty John B	Chief Legal Officer	Sell	2,374	$72.23	$171,474.02	-3.1%
Jan 7, 2026	MacLean Michael F	Chief Financial Officer	Sell	1,974	$72.23	$142,582.02	-3.0%
Jan 7, 2026	Hughes Steven George	Chief Medical Officer	Sell	2,373	$72.23	$171,401.79	-6.1%
Jan 7, 2026	Flanagan W. Michael	Chief Scientific Officer	Sell	2,373	$72.23	$171,401.79	-2.5%
Oct 22, 2025	Hughes Steven George	Chief Medical Officer	Sale+OE	2,209	$47.54	$105,014.53	-5.4%
Oct 15, 2025	McCarthy Teresa	Chief Human Resources Officer	Sale+OE	20,000	$50.15	$1,003,058.00	-17.1%
Oct 3, 2025	Mosbrooker Eric	Chief Commercial Officer	Sale+OE	6,562	$45.38	$297,771.09	-10.7%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC